267 related articles for article (PubMed ID: 23564467)
21. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
Sliz E; Sebert S; Würtz P; Kangas AJ; Soininen P; Lehtimäki T; Kähönen M; Viikari J; Männikkö M; Ala-Korpela M; Raitakari OT; Kettunen J
Hum Mol Genet; 2018 Jun; 27(12):2214-2223. PubMed ID: 29648650
[TBL] [Abstract][Full Text] [Related]
22. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
23. Ethnic differences in hepatic steatosis: an insulin resistance paradox?
Guerrero R; Vega GL; Grundy SM; Browning JD
Hepatology; 2009 Mar; 49(3):791-801. PubMed ID: 19105205
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
25. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
Speliotes EK; Butler JL; Palmer CD; Voight BF; ; ; ; Hirschhorn JN
Hepatology; 2010 Sep; 52(3):904-12. PubMed ID: 20648472
[TBL] [Abstract][Full Text] [Related]
26. Relevance of
Elmansoury N; Megahed AA; Kamal A; El-Nikhely N; Labane M; Abdelmageed M; Daly AK; Wahid A
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674389
[TBL] [Abstract][Full Text] [Related]
27. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
Serper M; Vujkovic M; Kaplan DE; Carr RM; Lee KM; Shao Q; Miller DR; Reaven PD; Phillips LS; O'Donnell CJ; Meigs JB; Wilson PWF; Vickers-Smith R; Kranzler HR; Justice AC; Gaziano JM; Muralidhar S; Pyarajan S; DuVall SL; Assimes TL; Lee JS; Tsao PS; Rader DJ; Damrauer SM; Lynch JA; Saleheen D; Voight BF; Chang KM;
PLoS One; 2020; 15(8):e0237430. PubMed ID: 32841307
[TBL] [Abstract][Full Text] [Related]
28. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.
Wagenknecht LE; Scherzinger AL; Stamm ER; Hanley AJ; Norris JM; Chen YD; Bryer-Ash M; Haffner SM; Rotter JI
Obesity (Silver Spring); 2009 Jun; 17(6):1240-6. PubMed ID: 19584882
[TBL] [Abstract][Full Text] [Related]
29. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.
Wruck W; Kashofer K; Rehman S; Daskalaki A; Berg D; Gralka E; Jozefczuk J; Drews K; Pandey V; Regenbrecht C; Wierling C; Turano P; Korf U; Zatloukal K; Lehrach H; Westerhoff HV; Adjaye J
Sci Data; 2015 Dec; 2():150068. PubMed ID: 26646939
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
[TBL] [Abstract][Full Text] [Related]
31. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.
Umano GR; Caprio S; Di Sessa A; Chalasani N; Dykas DJ; Pierpont B; Bale AE; Santoro N
Am J Gastroenterol; 2018 Mar; 113(3):376-383. PubMed ID: 29485130
[TBL] [Abstract][Full Text] [Related]
32. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
33. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study.
Wu MJ; Yuan C; Lu LL; An BQ; Xuan SY; Xin YN
Lipids Health Dis; 2016 Nov; 15(1):207. PubMed ID: 27887608
[TBL] [Abstract][Full Text] [Related]
34. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG
J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
[TBL] [Abstract][Full Text] [Related]
35. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries.
Rutledge SM; Soper ER; Ma N; Pejaver V; Friedman SL; Branch AD; Kenny EE; Belbin GM; Abul-Husn NS
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2578-2587.e11. PubMed ID: 36610497
[TBL] [Abstract][Full Text] [Related]
36. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
[TBL] [Abstract][Full Text] [Related]
37. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Liu YL; Reeves HL; Burt AD; Tiniakos D; McPherson S; Leathart JB; Allison ME; Alexander GJ; Piguet AC; Anty R; Donaldson P; Aithal GP; Francque S; Van Gaal L; Clement K; Ratziu V; Dufour JF; Day CP; Daly AK; Anstee QM
Nat Commun; 2014 Jun; 5():4309. PubMed ID: 24978903
[TBL] [Abstract][Full Text] [Related]
38. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
[TBL] [Abstract][Full Text] [Related]
39. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
[TBL] [Abstract][Full Text] [Related]
40. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
Cavalcante LN; Porto J; Mazo D; Longatto-Filho A; Stefano JT; Lyra AC; Carrilho FJ; Reis RM; Alves VAF; Sanyal AJ; Oliveira CP
Ann Hepatol; 2022; 27(6):100728. PubMed ID: 35710086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
